Related references
Note: Only part of the references are listed.Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
Jan de Kraker et al.
EUROPEAN JOURNAL OF CANCER (2008)
Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L
Xiaocai Yan et al.
JOURNAL OF IMMUNOLOGY (2008)
Dual targeting of the vascular endothelial growth factor receptor and epidermal growth factor receptor pathways with vandetinib (ZD6474) in patients with advanced or metastatic non-small cell lung cancer
Ronald B. Natale
JOURNAL OF THORACIC ONCOLOGY (2008)
ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma
Karina Jin Yoon et al.
PLOS ONE (2008)
Development of a Tumor-Selective Approach to Treat Metastatic Cancer
Karen S. Aboody et al.
PLOS ONE (2006)